Even though Rad51 is expressed at higher levels in tumour cells as compared with normal cells (Raderschall et al, 2002a), modulation of Rad51 expression has been shown to be more susceptible in tumour cells (Russell et al, 2003). The gene discussed is RAD51; the disease is neoplasm.